All Stories

  1. β-Cell Fate in Human Insulin Resistance and Type 2 Diabetes: A Perspective on Islet Plasticity

    Article • Diabetes, May 2019, American Diabetes Association

    Andrea Giaccari, Prof. Andrea Giaccari

  2. Increased β-Cell Workload Modulates Proinsulin-to-Insulin Ratio in Humans

    Article • Diabetes, August 2018, American Diabetes Association

    Andrea Giaccari

  3. FL-926-16, a novel bioavailable carnosinase-resistant carnosine derivative, prevents onset and stops progression of diabetic nephropathy indb/dbmice

    Article • British Journal of Pharmacology, December 2017, Wiley

    Professor Giuseppe Pugliese, Andrea Giaccari

  4. Better glycaemic control and less hypoglycaemia with insulin glargine 300 U/mL vs glargine 100 U/mL: 1-year patient-level meta-analysis of the EDITION clinical studies in people with type 2 diabetes

    Article • Diabetes Obesity and Metabolism, October 2017, Wiley

    Andrea Giaccari

  5. Spotlight on ertugliflozin and its potential in the treatment of type 2 diabetes: evidence to date

    Article • Drug Design Development and Therapy, October 2017, Dove Medical Press

    Andrea Giaccari

  6. A consensus statement for the clinical use of the renal sodium-glucose co-transporter-2 inhibitor dapagliflozin in patients with type 2 diabetes mellitus

    Article • Expert Review of Clinical Pharmacology, May 2017, Taylor & Francis

    Andrea Giaccari